Radiopharmaceuticals are drugs that contain radioactive materials, known as radioisotopes. These drugs may be administered by multiple routes and travel to the body to treat cancer or to reduce symptoms. Radiopharmaceuticals release radiation (alpha and beta particles) that target the affected areas.
Everyone responds to radiopharmaceuticals differently. Talk to your doctor or pharmacist about what to expect, including any side-effects you may experience while on these medications. Some therapies used to treat prostate cancer may interact with other prescription or non-prescription medications you are taking. Tell your doctor or pharmacist if you are taking any medications.
Below is a list of common radiopharmaceuticals used to treat prostate cancer. Click on each drug name for further information including:
  • what the drug is and how it works
  • how the drug is administered
  • possible side effects of the drug
  • whether the drug is covered by your provincial drug program

Radium 223 Dichloride (Xofigo)


Subscribe to our free monthly e-newsletter!

* indicates required


PCC Spotlight
Can exercise help slow prostate cancer growth?

Toronto, March 12, 2018 – Funded by Prostate Cancer Canada (PCC), Dr.

Prostate Cancer Canada’s Rock the Road Raffle sells out for 5th consecutive year

February 23, 2018 – TORONTO, ON – For the fifth year and counting, Prostate Cancer Canada’s (PCC) Rock the Road Raffle brought together Ontarians from all walks of life to both support an important cause and gain a chance to win a one-of-a-kind dream car.

Do men’s toenails contain clues about prostate cancer prevention?

Toronto, January 29, 2018 – Funded by Prostate Cancer Canada (PCC), Dr.

Click here for news archive